In Vivo Analysis of Viral Cyclin

病毒周期的体内分析

基本信息

  • 批准号:
    7362448
  • 负责人:
  • 金额:
    $ 23.38万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2004
  • 资助国家:
    美国
  • 起止时间:
    2004-04-15 至 2010-02-28
  • 项目状态:
    已结题

项目摘要

In Vivo Analysis of Viral Cyclin: Infection by herpesviruses causes an acute lytic infection that is rapidly cleared, and subsequent establishment of a latent infection that exists in balance with the host immune system for the lifetime of a healthy host. The gammaherpesviruses include the human pathogens, Epstein Barr virus and Kaposi's sarcoma herpesvirus, and the murine gammaherpesvirus-68 (gHV68). These viruses are related by sequence conservation, genomic organization, tropism, and associated pathologies. Latently infected cells express a limited set of viral genes, yet remain capable of reactivating lytic infection upon stimulation. Latency and reactivation from latency are associated with chronic disease and malignancies, particularly in immunocompromised hosts. Regulation of viral infection is a complex relationship between host and viral factors. These processes, from initial infection to latency and reactivation, are not well understood and have been constrained by the difficulties of studying higher mammalian host systems. The murine gHV68 model system provides a tractable small animal model in which both pathogen and host are genetically manipulable, and enables study of virus and host interactions through the entire course of viral infection. Previous utilization of gHV68 as a model system to study cell cycle regulation in viral infection demonstrated that the gHV68 viral cyclin promotes cell cycle progression and acts as an oncogene when expressed as a transgene in primary lymphocytes. The gHV68 viral cyclin is not required for any aspect of lytic infection, but is essential for efficient reactivation from latency. This proposal will address the mechanism of action of the gHV68 viral cyclin in infection. First, what is the expression pattern of the viral cyclin in infection? Second, what are the catalytic partners and the substrates of the viral cyclins in vivo? Third, are the unique features of the viral cyclins essential to their role in viral infection?
在病毒周期蛋白的活体分析中:疱疹病毒感染会引起急性裂解性感染,这种感染会迅速清除,随后会建立一种潜伏感染,在健康宿主的一生中与宿主免疫系统保持平衡。伽马疱疹病毒包括人类病原体、爱泼斯坦-巴尔病毒和卡波西肉瘤疱疹病毒,以及小鼠伽马疱疹病毒-68(GHV68)。这些病毒与序列保守性、基因组组织、嗜性和相关的病理学有关。潜伏感染的细胞表达一组有限的病毒基因,但仍能在刺激下重新激活裂解感染。潜伏期和潜伏期的重新激活与慢性病和恶性肿瘤有关,特别是在免疫受损的宿主中。病毒感染的调控是宿主和病毒因子之间的复杂关系。这些过程,从最初的感染到潜伏和重新激活,还没有被很好地理解,并且受到研究高等哺乳动物寄主系统的困难的限制。小鼠ghv68模型系统提供了一个易于处理的小动物模型,在该模型中病原体和宿主都是可遗传操纵的,并且能够研究病毒和宿主之间的相互作用。 在病毒感染的整个过程中。以前利用gHV68作为研究病毒感染中细胞周期调控的模型系统表明,gHV68病毒周期蛋白在原代淋巴细胞中以转基因的形式表达时,促进了细胞周期的进展,并发挥了癌基因的作用。GHV68病毒周期蛋白对溶血性感染的任何方面都不是必需的,但对于从潜伏期有效地重新激活是必不可少的。这项提案将解决gHV68病毒周期蛋白在感染中的作用机制。首先,病毒周期蛋白在感染中的表达模式是什么?第二,病毒周期蛋白在体内的催化伙伴和底物是什么?第三,病毒周期蛋白的独特特性是否对它们的作用至关重要? 在病毒感染中?

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Linda F. Van Dyk其他文献

Linda F. Van Dyk的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Linda F. Van Dyk', 18)}}的其他基金

Non-coding RNAs in Gammaherpesvirus Infection and Disease
伽马疱疹病毒感染和疾病中的非编码 RNA
  • 批准号:
    9263885
  • 财政年份:
    2016
  • 资助金额:
    $ 23.38万
  • 项目类别:
Cyclin requirements in gammaherpesvirus infection and disease
伽马疱疹病毒感染和疾病中的细胞周期素需求
  • 批准号:
    8685199
  • 财政年份:
    2012
  • 资助金额:
    $ 23.38万
  • 项目类别:
Regulation of Herpesvirus Infection by Viral miRNAs
病毒 miRNA 对疱疹病毒感染的调控
  • 批准号:
    8535928
  • 财政年份:
    2012
  • 资助金额:
    $ 23.38万
  • 项目类别:
Cyclin requirements in gammaherpesvirus infection and disease
伽马疱疹病毒感染和疾病中的细胞周期素需求
  • 批准号:
    8456067
  • 财政年份:
    2012
  • 资助金额:
    $ 23.38万
  • 项目类别:
Cyclin requirements in gammaherpesvirus infection and disease
伽马疱疹病毒感染和疾病中的细胞周期素需求
  • 批准号:
    8329877
  • 财政年份:
    2012
  • 资助金额:
    $ 23.38万
  • 项目类别:
Cyclin requirements in gammaherpesvirus infection and disease
伽马疱疹病毒感染和疾病中的细胞周期素需求
  • 批准号:
    8852568
  • 财政年份:
    2012
  • 资助金额:
    $ 23.38万
  • 项目类别:
Characterization of an animal model of chronic infection and disease
慢性感染和疾病动物模型的表征
  • 批准号:
    7835663
  • 财政年份:
    2009
  • 资助金额:
    $ 23.38万
  • 项目类别:
Characterization of an animal model of chronic infection and disease
慢性感染和疾病动物模型的表征
  • 批准号:
    7642162
  • 财政年份:
    2009
  • 资助金额:
    $ 23.38万
  • 项目类别:
In Vivo Analysis of Viral Cyclin
病毒周期的体内分析
  • 批准号:
    7119331
  • 财政年份:
    2004
  • 资助金额:
    $ 23.38万
  • 项目类别:
In Vivo Analysis of Viral Cyclin
病毒周期的体内分析
  • 批准号:
    7022221
  • 财政年份:
    2004
  • 资助金额:
    $ 23.38万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 23.38万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.38万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 23.38万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.38万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 23.38万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.38万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 23.38万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 23.38万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 23.38万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.38万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了